Author
Listed:
- Ahmed Al-Imam
(Poznan University of Medical Sciences
Poznan University of Medical Sciences
University of Baghdad)
- Riccardo Lora
(University of Verona)
- Marek A. Motyka
(University of Rzeszow)
- Erica Marletta
(University of Verona)
- Michele Vezzaro
(University of Verona)
- Jerzy Moczko
(Poznan University of Medical Sciences)
- Manal Younus
(Ministry of Health
The Middle East Chapter, The International Society of Pharmacovigilance (ISoP)
Council for International Organizations of Medical Sciences (CIOMS))
- Michal Michalak
(Poznan University of Medical Sciences)
Abstract
Background Psychedelics are gaining attention for their therapeutic potential in modern and personalized medicine. Online forums such as Erowid provide valuable user insights, but analyses of these experiences using natural language processing (NLP) remain scarce. Objective This study aims to utilize NLP, including sentiment and lexicon analysis, to examine user-generated experience reports on psilocybin-containing mushrooms and LSD from the Erowid forum. Methods Data from 2188 Erowid users (1161 psilocybin mushrooms and 1027 LSD) was collected via automated web scraping with XPath, CSS selectors, and Selenium WebDriver. The dataset included report titles, substances, and demographics. Sentiment analysis utilized BERT, RoBERTa, and VADER models. Preprocessing involved tokenization, lemmatization, part-of-speech tagging, and stop-word filtering. Lexicon analysis identified themes through recurring n-grams, visualized using Python. Results User demographics revealed comparable ages for psilocybin mushrooms (23.8 ± 0.9 years) and LSD users (20.0 ± 0.6 years), with a predominance of male users. The BERT model predominantly labeled experiences as negative (unfavorable), particularly for mushroom users (p = 0.001). VADER indicated more positive experiences for mushroom users (p
Suggested Citation
Ahmed Al-Imam & Riccardo Lora & Marek A. Motyka & Erica Marletta & Michele Vezzaro & Jerzy Moczko & Manal Younus & Michal Michalak, 2025.
"Opinion Mining of Erowid’s Experience Reports on LSD and Psilocybin-Containing Mushrooms,"
Drug Safety, Springer, vol. 48(5), pages 559-575, May.
Handle:
RePEc:spr:drugsa:v:48:y:2025:i:5:d:10.1007_s40264-025-01530-z
DOI: 10.1007/s40264-025-01530-z
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:48:y:2025:i:5:d:10.1007_s40264-025-01530-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.